What happened?
WHO’s Weekly Epidemiological Record (week 40, 2026) reports that global influenza and RSV positivity remained low (influenza below 10% overall), while SARS‑CoV‑2 positivity was stable and low. Influenza A viruses were predominant globally, though some regions and single countries showed elevated influenza activity and differing subtype patterns.
Why does it matter?
The bulletin summarises routine surveillance through the WHO Global Influenza Surveillance and Response System. Low global positivity suggests limited circulation overall, but higher activity in some countries signals ongoing local transmission and variable subtype dominance that can affect seasonal risk.
How to interpret the evidence
The report covers global surveillance data and national reports; applicability to Malta or EU depends on local surveillance and national public‑health guidance. The update includes regional heterogeneity and small‑scale increases, so national authorities should interpret trends using local data and WHO guidance on vaccine composition and seasonality.
What remains uncertain?
Low global positivity does not mean no risk. Elevated activity in specific countries, differing dominant subtypes, and surveillance gaps mean local outbreaks remain possible. The bulletin describes surveillance findings and does not imply new treatments, approvals or local vaccine availability in Malta or the EU.
Medical News provides general health education. Individual treatment decisions depend on your circumstances and the advice of your clinical team.
This summary was prepared with AI assistance and checked automatically against the linked primary source. It has not been individually reviewed by a clinician.